RATIONALE: The standard approach to diagnosis of primary ciliary dyskinesia (PCD) in the United Kingdom consists of assessing ciliary function by high-speed microscopy and ultrastructure by election microscopy, but equipment and expertise is not widely available internationally. The identification of biallelic disease-causing mutations is also diagnostic, but many disease-causing genes are unknown, and testing is not widely available outside the United States. Fluorescent antibodies to ciliary proteins are used to validate research genetic studies, but diagnostic utility in this disease has not been systematically evaluated. OBJECTIVES: To determine utility of a panel of six fluorescent labeled antibodies as a diagnostic tool for PCD. METHODS: The study used immunofluorescent labeling of nasal brushings from a discovery cohort of 35 patients diagnosed with PCD by ciliary ultrastructure, and a diagnostic accuracy cohort of 386 patients referred with symptoms suggestive of disease. The results were compared with diagnostic outcome. MEASUREMENTS AND MAIN RESULTS: Immunofluorescence correctly identified mislocalized or absent staining in 100% of the discovery cohort. In the diagnostic cohort immunofluorescence successfully identified 22 of 25 patients with PCD and normal staining in all 252 in whom PCD was considered highly unlikely. In addition, immunofluorescence provided a result in 55% (39) of cases that were previously inconclusive. Immunofluorescence results were available within 14 days, costing $187 per sample compared with electron microscopy (27 days; cost $1,452). CONCLUSIONS: Immunofluorescence is a highly specific diagnostic test for PCD, and it improves the speed and availability of diagnostic testing. However, sensitivity is limited and immunofluorescence is not suitable as a stand-alone test.
RATIONALE: The standard approach to diagnosis of primary ciliary dyskinesia (PCD) in the United Kingdom consists of assessing ciliary function by high-speed microscopy and ultrastructure by election microscopy, but equipment and expertise is not widely available internationally. The identification of biallelic disease-causing mutations is also diagnostic, but many disease-causing genes are unknown, and testing is not widely available outside the United States. Fluorescent antibodies to ciliary proteins are used to validate research genetic studies, but diagnostic utility in this disease has not been systematically evaluated. OBJECTIVES: To determine utility of a panel of six fluorescent labeled antibodies as a diagnostic tool for PCD. METHODS: The study used immunofluorescent labeling of nasal brushings from a discovery cohort of 35 patients diagnosed with PCD by ciliary ultrastructure, and a diagnostic accuracy cohort of 386 patients referred with symptoms suggestive of disease. The results were compared with diagnostic outcome. MEASUREMENTS AND MAIN RESULTS: Immunofluorescence correctly identified mislocalized or absent staining in 100% of the discovery cohort. In the diagnostic cohort immunofluorescence successfully identified 22 of 25 patients with PCD and normal staining in all 252 in whom PCD was considered highly unlikely. In addition, immunofluorescence provided a result in 55% (39) of cases that were previously inconclusive. Immunofluorescence results were available within 14 days, costing $187 per sample compared with electron microscopy (27 days; cost $1,452). CONCLUSIONS: Immunofluorescence is a highly specific diagnostic test for PCD, and it improves the speed and availability of diagnostic testing. However, sensitivity is limited and immunofluorescence is not suitable as a stand-alone test.
Authors: Adrien Frommer; Rim Hjeij; Niki T Loges; Christine Edelbusch; Charlotte Jahnke; Johanna Raidt; Claudius Werner; Julia Wallmeier; Jörg Große-Onnebrink; Heike Olbrich; Sandra Cindrić; Martine Jaspers; Mieke Boon; Yasin Memari; Richard Durbin; Anja Kolb-Kokocinski; Sascha Sauer; June K Marthin; Kim G Nielsen; Israel Amirav; Nael Elias; Eitan Kerem; David Shoseyov; Karsten Haeffner; Heymut Omran Journal: Am J Respir Cell Mol Biol Date: 2015-10 Impact factor: 6.914
Authors: Heike Olbrich; Miriam Schmidts; Claudius Werner; Alexandros Onoufriadis; Niki T Loges; Johanna Raidt; Nora Fanni Banki; Amelia Shoemark; Tom Burgoyne; Saeed Al Turki; Matthew E Hurles; Gabriele Köhler; Josef Schroeder; Gudrun Nürnberg; Peter Nürnberg; Eddie M K Chung; Richard Reinhardt; June K Marthin; Kim G Nielsen; Hannah M Mitchison; Heymut Omran Journal: Am J Hum Genet Date: 2012-09-27 Impact factor: 11.025
Authors: Niki Tomas Loges; Heike Olbrich; Anita Becker-Heck; Karsten Häffner; Angelina Heer; Christina Reinhard; Miriam Schmidts; Andreas Kispert; Maimoona A Zariwala; Margaret W Leigh; Michael R Knowles; Hanswalter Zentgraf; Horst Seithe; Gudrun Nürnberg; Peter Nürnberg; Richard Reinhardt; Heymut Omran Journal: Am J Hum Genet Date: 2009-12 Impact factor: 11.025
Authors: A Barbato; T Frischer; C E Kuehni; D Snijders; I Azevedo; G Baktai; L Bartoloni; E Eber; A Escribano; E Haarman; B Hesselmar; C Hogg; M Jorissen; J Lucas; K G Nielsen; C O'Callaghan; H Omran; P Pohunek; M-P F Strippoli; A Bush Journal: Eur Respir J Date: 2009-12 Impact factor: 16.671
Authors: Dinu Antony; Anita Becker-Heck; Maimoona A Zariwala; Miriam Schmidts; Alexandros Onoufriadis; Mitra Forouhan; Robert Wilson; Theresa Taylor-Cox; Ann Dewar; Claire Jackson; Patricia Goggin; Niki T Loges; Heike Olbrich; Martine Jaspers; Mark Jorissen; Margaret W Leigh; Whitney E Wolf; M Leigh Anne Daniels; Peadar G Noone; Thomas W Ferkol; Scott D Sagel; Margaret Rosenfeld; Andrew Rutman; Abhijit Dixit; Christopher O'Callaghan; Jane S Lucas; Claire Hogg; Peter J Scambler; Richard D Emes; Eddie M K Chung; Amelia Shoemark; Michael R Knowles; Heymut Omran; Hannah M Mitchison Journal: Hum Mutat Date: 2013-02-11 Impact factor: 4.878
Authors: Alexandros Onoufriadis; Amelia Shoemark; Miriam Schmidts; Mitali Patel; Gina Jimenez; Hui Liu; Biju Thomas; Mellisa Dixon; Robert A Hirst; Andrew Rutman; Thomas Burgoyne; Christopher Williams; Juliet Scully; Florence Bolard; Jean-Jacques Lafitte; Philip L Beales; Claire Hogg; Pinfen Yang; Eddie M K Chung; Richard D Emes; Christopher O'Callaghan; Patrice Bouvagnet; Hannah M Mitchison Journal: Hum Mol Genet Date: 2014-02-11 Impact factor: 6.150
Authors: Andrew R Turnbull; Ronan Murphy; Volker Behrends; Helena Lund-Palau; Ameze Simbo; Myril Mariveles; Eric W F W Alton; Andrew Bush; Amelia Shoemark; Jane C Davies Journal: Am J Respir Crit Care Med Date: 2018-06-15 Impact factor: 21.405
Authors: Mahmoud R Fassad; Amelia Shoemark; Pierrick le Borgne; France Koll; Mitali Patel; Mellisa Dixon; Jane Hayward; Charlotte Richardson; Emily Frost; Lucy Jenkins; Thomas Cullup; Eddie M K Chung; Michel Lemullois; Anne Aubusson-Fleury; Claire Hogg; David R Mitchell; Anne-Marie Tassin; Hannah M Mitchison Journal: Am J Hum Genet Date: 2018-05-03 Impact factor: 11.025
Authors: Jonathan Grigg; Jürg Barben; Mark L Everard; Graham Hall; Bülent Karadag; Alexander Moeller; Raffaella Nenna; Kostas N Priftis; Robbert J Rottier; Suzanne W J Terheggen-Lagro; Fabio Midulla Journal: ERJ Open Res Date: 2018-05-25
Authors: Florian Halbeisen; Claire Hogg; Mikkel C Alanin; Zuzanna Bukowy-Bieryllo; Francisco Dasi; Julie Duncan; Amanda Friend; Myrofora Goutaki; Claire Jackson; Victoria Keenan; Amanda Harris; Robert A Hirst; Philipp Latzin; Gemma Marsh; Kim Nielsen; Dominic Norris; Daniel Pellicer; Ana Reula; Bruna Rubbo; Nisreen Rumman; Amelia Shoemark; Woolf T Walker; Claudia E Kuehni; Jane S Lucas Journal: BMC Proc Date: 2018-03-05